BotVax B (Canada)

Manufacturer: Centaur

Clostridium Botulinum Type B Toxoid

Purified botulinum type B toxoid aluminum phosphate adsorbed.

Preservative: 0.01% Thimerosal.

Contains no more than 0.2% formaldehyde as inactivating solution.

BotVax B Indications

For the prevention of botulism due to Clostridium botulinum, Type B in healthy horses.

Dosage

Inject 2.0 mL intramuscularly at monthly intervals for a total of 3 doses. Booster annually with a single 2.0 mL intramuscular dose.

Research has demonstrated that pregnant mares immunized during the third trimester of gestation, with the third dose (booster) given 2 - 4 weeks before parturition, respond with antibody. This antibody is concentrated in colostrum and results in significant passively acquired antibody in normal sulking foals.

Administration

Inject intramuscularly using aseptic technique. Shake well before use.

BotVax B Cautions

Transitory local reactions at the injection site such as heat and minor swelling may occur. Anaphylactoid reactions may occur. Epinephrine is antidotal. Store at 2 - 7°C (35 - 45°F). Do not freeze. Use the entire contents when opened. Do not vaccinate food producing animals within 21 days of slaughter.

This is a conditionally licensed vaccine. Efficacy and potency have not been determined. These studies are in progress.

For Veterinary Use Only

U.s. Vet. Lic. No. 302

10 mL - 5 Doses

L309-0300

Nac No.

12210011